CARU company
The primary focus of the Clinical Ageing Research Unit (CARU) is research into conditions associated with ageing. Their aim is to facilitate the development of early assessment and intervention strategies targeted at age-associated degenerative conditions.The earliest studies taking place in CARU have a strong emphasis on neurodegenerative disease. (Dementia and Parkinson's Desiase in the main focus)
Headquarters:
Newcastle upon Tyne, England, United Kingdom
Technology:
Geroscience
Employee Number:
Undisclosed
Industry:
Geroscience
Number Of Exists:
N/A
Funding Status:
N/A
Investor Type:
Research Labs
Investment Stage:
N/A